145 related articles for article (PubMed ID: 36170758)
1. Establishment of a human induced pluripotent stem cell line, KMUGMCi005-A, from a patient with Epidermodysplasia verruciformis (EV) bearing homozygous splicing donor site mutation in the TMC8 gene.
Ura H; Togi S; Hatanaka H; Niida Y
Stem Cell Res; 2022 Oct; 64():102926. PubMed ID: 36170758
[TBL] [Abstract][Full Text] [Related]
2. Establishment of a human induced pluripotent stem cell line, KMUGMCi007-A, from a patient with prolidase deficiency (PD) bearing homozygous in-frame mutation in the PEPD gene.
Ura H; Togi S; Ozaki M; Hatanaka H; Niida Y
Stem Cell Res; 2023 Jun; 69():103075. PubMed ID: 37023562
[TBL] [Abstract][Full Text] [Related]
3. TMC8 mutation in a Turkish family with epidermodysplasia verruciformis including laryngeal papilloma and recurrent skin carcinoma.
Esenboga S; Cagdas D; Alkanat NE; Güler Tezel G; Ersoy Evans S; Boztug K; Tezcan I
J Cosmet Dermatol; 2022 May; 21(5):2263-2267. PubMed ID: 34416085
[TBL] [Abstract][Full Text] [Related]
4. Epidermodysplasia verruciformis in a HIV-positive patient homozygous for the c917A-->T polymorphism in the TMC8/EVER2 gene.
Hohenstein E; Rady PL; Hergersberg M; Huber AR; Tyring SK; Bregenzer T; Streit M; Itin P
Dermatology; 2009; 218(2):114-8. PubMed ID: 19005244
[TBL] [Abstract][Full Text] [Related]
5. Novel TMC8 splice site mutation in epidermodysplasia verruciformis and review of HPV infections in patients with the disease.
Imahorn E; Yüksel Z; Spoerri I; Gürel G; Imhof C; Saraçoğlu ZN; Koku Aksu AE; Rady PL; Tyring SK; Kempf W; Itin PH; Burger B
J Eur Acad Dermatol Venereol; 2017 Oct; 31(10):1722-1726. PubMed ID: 28646613
[TBL] [Abstract][Full Text] [Related]
6. Epidermodysplasia verruciformis with squamous cell carcinomas and the identification of a novel TMC8 mutation.
Kuriyama Y; Yasuda M; Saito S; Nakano H; Shimizu A; Tamura A; Motegi SI
J Dermatol; 2023 Oct; 50(10):e325-e326. PubMed ID: 37183530
[No Abstract] [Full Text] [Related]
7. Novel homozygous frameshift mutation of EVER1 gene in an epidermodysplasia verruciformis patient.
Gober MD; Rady PL; He Q; Tucker SB; Tyring SK; Gaspari AA
J Invest Dermatol; 2007 Apr; 127(4):817-20. PubMed ID: 17139267
[TBL] [Abstract][Full Text] [Related]
8. Genetic analysis of a novel splice-site mutation in TMC8 reveals the in vivo importance of the transmembrane channel-like domain of TMC8.
Miyauchi T; Nomura T; Suzuki S; Takeda M; Shinkuma S; Arita K; Fujita Y; Shimizu H
Br J Dermatol; 2016 Oct; 175(4):803-6. PubMed ID: 26997147
[No Abstract] [Full Text] [Related]
9. Epidermodysplasia verruciformis.
Burger B; Itin PH
Curr Probl Dermatol; 2014; 45():123-31. PubMed ID: 24643182
[TBL] [Abstract][Full Text] [Related]
10. Establishment of a human induced pluripotent stem cell line, KMUGMCi003-A, from a patient with trichothiodystrophy 1 (TTD1) bearing compound heterozygous missense mutations in the ERCC2 gene.
Ura H; Togi S; Hatanaka H; Niida Y
Stem Cell Res; 2022 Oct; 64():102885. PubMed ID: 35944311
[TBL] [Abstract][Full Text] [Related]
11. Genetics of epidermodysplasia verruciformis: Insights into host defense against papillomaviruses.
Orth G
Semin Immunol; 2006 Dec; 18(6):362-74. PubMed ID: 17011789
[TBL] [Abstract][Full Text] [Related]
12. Identification and Splicing Characterization of Novel
Wang R; Liu J; Yang X; Habulieti X; Yu X; Sun L; Zhang H; Sun Y; Ma D; Zhang X
Front Genet; 2021; 12():712275. PubMed ID: 34386043
[No Abstract] [Full Text] [Related]
13. A homozygous nonsense mutation in the EVER2 gene leads to epidermodysplasia verruciformis.
Sun XK; Chen JF; Xu AE
Clin Exp Dermatol; 2005 Sep; 30(5):573-4. PubMed ID: 16045695
[TBL] [Abstract][Full Text] [Related]
14. Autosomal dominant epidermodysplasia verruciformis lacking a known EVER1 or EVER2 mutation.
McDermott DF; Gammon B; Snijders PJ; Mbata I; Phifer B; Howland Hartley A; Lee CC; Murphy PM; Hwang ST
Pediatr Dermatol; 2009; 26(3):306-10. PubMed ID: 19706093
[TBL] [Abstract][Full Text] [Related]
15. Re-evaluation of epidermodysplasia verruciformis: Reconciling more than 90 years of debate.
Przybyszewska J; Zlotogorski A; Ramot Y
J Am Acad Dermatol; 2017 Jun; 76(6):1161-1175. PubMed ID: 28196644
[TBL] [Abstract][Full Text] [Related]
16. Treatment of a patient with epidermodysplasia verruciformis carrying a novel EVER2 mutation with imiquimod.
Berthelot C; Dickerson MC; Rady P; He Q; Niroomand F; Tyring SK; Pandya AG
J Am Acad Dermatol; 2007 May; 56(5):882-6. PubMed ID: 17368633
[TBL] [Abstract][Full Text] [Related]
17. Novel homozygous nonsense TMC8 mutation detected in patients with epidermodysplasia verruciformis from a Brazilian family.
Rady PL; De Oliveira WR; He Q; Festa C; Rivitti EA; Tucker SB; Tyring SK
Br J Dermatol; 2007 Oct; 157(4):831-3. PubMed ID: 17711520
[No Abstract] [Full Text] [Related]
18. Identification of LCK mutation in a family with atypical epidermodysplasia verruciformis with T-cell defects and virus-induced squamous cell carcinoma.
Li SL; Duo LN; Wang HJ; Dai W; Zhou EH; Xu YN; Zhao T; Xiao YY; Xia L; Yang ZH; Zheng LT; Hu YY; Lin ZM; Wang HN; Gao TW; Ma CL; Yang Y; Li CY
Br J Dermatol; 2016 Dec; 175(6):1204-1209. PubMed ID: 27087313
[TBL] [Abstract][Full Text] [Related]
19. Whole transcriptome-based skin virome profiling in typical epidermodysplasia verruciformis reveals α-, β-, and γ-HPV infections.
Saeidian AH; Youssefian L; Naji M; Mahmoudi H; Barnada SM; Huang C; Naghipoor K; Hozhabrpour A; Park JS; Manzo Margiotta F; Vahidnezhad F; Saffarian Z; Kamyab-Hesari K; Tolouei M; Faraji N; Azimi SZ; Namdari G; Mansouri P; Casanova JL; Béziat V; Jouanguy E; Uitto J; Vahidnezhad H
JCI Insight; 2023 Mar; 8(5):. PubMed ID: 36602881
[TBL] [Abstract][Full Text] [Related]
20. Establishment of a human induced pluripotent stem cell line, KMUGMCi002-A, from a patient bearing a heterozygous c.6362_6364del mutation in the NIPBL gene leading Cornelia de Lange syndrome (CdLS).
Ura H; Togi S; Iwata Y; Ozaki M; Niida Y
Stem Cell Res; 2022 Aug; 63():102860. PubMed ID: 35834947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
